Orange County NC Website
5Y7 ) q: ) <br /> Supplemental Agreement for Additional Funds <br /> From Additional Settlements of Opioid Litigation <br /> I . PURPOSE <br /> The purpose of this Supplemental Agreement for Additional Funds (" SAAF" ) is to <br /> direct Additional Funds from Additional Settlements of opiold litigation to the state <br /> of North Carolina and local governments in a manner consistent with the <br /> Memorandum of Agreement ("MOA ' ) Between the State of North Carolina and <br /> Local Governments on Proceeds Relating to the Settlement of Opioid Litigation that <br /> has governed the distribution of Oploid Settlement Funds to the State and its Local <br /> Governments since May 2022 . <br /> This SAAF does not change the scope or meaning of the MOA with respect to Opiold <br /> Settlement Funds governed by the MOA . Instead, this SAAF applies the terms of <br /> the MOA — with certain clarifications noted below — to the Additional Settlements <br /> and Additional Funds described below . <br /> II . SCOPE <br /> A . Scope of the MOA . Under the terms of the MOA, the MOA governs Opioid <br /> Settlement Funds from : <br /> 1 . The National Settlement Agreement with the drug distributors <br /> Cardinal , McKesson, and AmerisourceBergen and the drug maker <br /> Johnson & Johnson and its subsidiary Janssen Pharmaceuticals ; and <br /> 2 . The Bankruptcy Resolution with Mallinckrodt ; any Bankruptcy <br /> Resolution with Purdue ; and any other Bankruptcy Resolution as the <br /> term "Bankruptcy Resolution" is defined in the MOA . <br /> B . Scope of this SAAF . This SAAF governs Additional Funds from the <br /> Additional Settlements with Additional Settling Defendants Walmart , Inc . , <br /> Teva Pharmaceutical Industries Ltd . , Allergan Finance , LLC , Allergan <br /> Limited, CVS Health Corporation, CVS Pharmacy, Inc . , and Walgreen Co . , as <br /> well as their subsidiaries , affiliates , officers , and directors named in the <br /> Additional Settlements . <br /> 1 <br />